(Untitle)On March 9, SK chemicals held its 38th ordinary shareholders’ meeting at Sky Hall on the first floor of its headquarters. The meeting approved the 38th term business results, a partial amendment to its Articles of Association, the naming of executive directors, and the remuneration of executive directors.
SK chemicals posted a net profit of 29.2 billion won from 872.5 billion won in sales. The meeting of the Board of Directors, following the shareholders’ meeting, was held to reappoint SK chemicals’ Life Science CEO Shin Seung-kwon, whose tenure had expired, and to name Park Chan-jung as a director.